ASLAN Pharmaceuticals Disclosed Late Breaking Abstract On Eblasakimab In COPD Accepted For Presentation At The American Thoracic Society International Conference
ASLAN Pharmicals披露了慢性阻塞性肺病中Eblasakimab的最新摘要獲准在美國胸科學會國際會議上發表
ASLAN Pharmaceuticals Disclosed Late Breaking Abstract On Eblasakimab In COPD Accepted For Presentation At The American Thoracic Society International Conference
ASLAN Pharmicals披露了慢性阻塞性肺病中Eblasakimab的最新摘要獲准在美國胸科學會國際會議上發表
使用瀏覽器的分享功能,分享給你的好友吧